Psilocybin for quitting methamphetamine
Treatments studied
Part of Mental health clinical trials.
This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 65 years old.
- Methamphetamine is your main drug of choice and you want to stop using it completely.
- You have been in treatment at a local facility for at least 7 days.
- You can speak English and do not have other serious addictions (except nicotine or cannabis).
- You are willing to attend several therapy sessions, including telehealth calls and in-person visits.
- You have no major health problems like heart disease, uncontrolled high blood pressure, or a history of seizures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether psilocybin, a psychedelic substance, can help people with moderate to severe methamphetamine use disorder reduce or stop their use. It may work by helping the brain reset, but it's not a standard treatment and involves careful monitoring.
This trial tests whether psilocybin (a psychedelic medicine) can help people who use methamphetamine and are living with HIV reduce or stop their meth use. You would receive psilocybin in a supervised setting and get counseling support to help you reach your goal of quitting.
This study tests whether people who use methamphetamine can reduce use even if they are not completely abstinent. It offers a 12-week program and checks how you're doing for another 12 weeks after.
This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.
This study provides extra support to help people with heart failure who use methamphetamine to quit. The goal is to see if this support helps improve their heart health and overall well-being.
This trial tests a new brain stimulation treatment called TMS (transcranial magnetic stimulation) to help reduce methamphetamine use and its effects. It uses a closed loop, meaning the stimulation adjusts based on your brain activity, and may help with core symptoms of addiction.
Hear when a new Methamphetamine Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.